Clinical trials: Dystonia Disorder

Torticollis (Spasmodic)

Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia

• Completed
• Age: 30 to 75 years
• Phase 2

This is an open-label, dose-escalation study to assess the safety and preliminary efficacy of daxibotulinumtoxinA in subjects with isolated cervical dystonia (CD).

Trial name

NCT02706795

Testing

DaxibotulinumtoxinA

Where

13 sites in United States

Volunteers

37 people

Sponsor

Revance Therapeutics, Inc.